DaCapo's mission is to develop the first disease-modifying therapies for neurodegenerative diseases.
| Website | https://www.dacapobrain.com |
| Employees | 13 (10 on RocketReach) |
| Founded | 2020 |
| Address | 238 Main St, Cambridge, Massachusetts 02142, US |
| Industry | Biotechnology Research |
| Keywords | Neurodegenerative Diseases, Alzheimers Treatment, Disease Modifying Therapies, Neurological Disorders, Brain Health, Cognitive Decline, Drug Discovery, Clinical Trials, Neuroscience Research, Biotechnology, Pharmaceutical Research, Neuroprotection, Regenerative Medicine, Brain Research, Cognitive Enhancement, Memory Loss, Dementia Treatment, Nervous System Diseases, Central Nervous System |
| Competitors | Cognex Corporation, NeuroMetrix, Inc., BioWave Corporation, BrainCo_Tech, Wave Neuroscience, MindMaze, EMOTIV, NeuroSky, Cerebellum Corporation, NextMind +25 more (view full list) |
Looking for a particular DaCapo Brainscience employee's phone or email?
Leslie Williams is the President and CEO of DaCapo Brainscience.
10 people are employed at DaCapo Brainscience.
DaCapo Brainscience is based in Cambridge, Massachusetts.